Optimizing renal replacement therapy - A case for online filtration therapies?

Nephrology Dialysis Transplantation

Volumn 17, Issue 12, 2002, Pages 2065-2070

  Beerenhout, Charles H ^a   Kooman, Jeroen P ^a   Luik, Antinus J ^b   Jeuken Mertens, Suzzanne G J ^b   van der Sande, Frank M ^a   Leunissen, Karel M L ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b St Maartens Gasthuis ^*  (Netherlands)

Author keywords

Convective therapy; Online filtration; Solute clearance; Sterility

Indexed keywords

ANTIHYPERTENSIVE AGENT; APOLIPOPROTEIN A1; BETA 2 MICROGLOBULIN; CALCITONIN; CALCIUM; COMPLEMENT FACTOR D; CYTOKINE; ENDOTOXIN; NITRIC OXIDE; PLASMA PROTEIN; POLYAMIDE; POLYSULFONE; SODIUM; TOXIN; VASODILATOR AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; COST BENEFIT ANALYSIS; DIALYSIS; DIALYSIS MEMBRANE; HEMODYNAMICS; HEMOFILTRATION; HUMAN; INTERMETHOD COMPARISON; KIDNEY CLEARANCE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MEMBRANE PERMEABILITY; MOLECULAR SIZE; NONHUMAN; ONLINE SYSTEM; PATHOGENESIS; PRIORITY JOURNAL; THERMODYNAMICS; COMPUTER ASSISTED THERAPY; ECONOMICS; EVALUATION; HEALTH CARE COST; HEMODIAFILTRATION; METHODOLOGY; RENAL REPLACEMENT THERAPY; REVIEW; SAFETY;

HEALTH CARE COSTS; HEMODIAFILTRATION; HUMANS; RENAL DIALYSIS; RENAL REPLACEMENT THERAPY; SAFETY; THERAPY, COMPUTER-ASSISTED;

EID: 0036900108     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/17.12.2065     Document Type: Article

References (60)

1. Ledebo I. Does convective dialysis therapy applied daily approach renal blood purification? Kidney Int 2001; 78 [Suppl]: S286-S291
2. Tetta C, Ghezzi PM, de Nitti C, Fiorenza A, Cianciavecchia D, Gervasio R. New options for online hemodiafiltration. Contrib Nephrol 2002; 137: 212-220
3. Ding F, Ahrenholz P, Winkler RE et al. Online hemodiafiltration versus acetate-free biofiltration: a prospective crossover study. Artif Organs 2002; 26: 169-180
4. Furst P, Asaba M, Gordon A, Zimmerman L, Bergstrom J. Middle molecules in uraemia. Proc Eur Dial Transplant Assoc 1975; 11: 417-426
5. Vanholder R, De Smet R, Vogeleere P, Ringoir S. Middle molecules: toxicity and removal by hemodialysis and related strategies. Artif Organs 1995; 19: 1120-1125
6. Horl WH. Uremic toxins: new aspects. J Nephrol 2000; 13 [Suppl 3]: S83-S88
7. Vlassara H, Brownlee M, Manogue KR, Dinarello CA, Pasagian A. Cachectin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodeling. Science 1988; 240: 1546-1548
8. Kaysen GA. The microinflammatory state in uremia: causes and potential consequences. J Am Soc Nephrol 2001; 12: 1549-1557
9. Makita Z, Bucala R, Rayfield EJ et al. Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure. Lancet 1994; 343: 1519-1522
10. Kamanna VS, Kashyap ML, Pai R et al. Uremic serum subfraction inhibits apolipoprotein A-I production by a human hepatoma cell line. J Am Soc Nephrol 1994; 5: 193-200
11. Anderstam B, Mamoun AH, Sodersten P et al. Middle-sized molecule fractions isolated from uremic ultrafiltrate and normal urine inhibit ingestive behavior in the rat. J Am Soc Nephrol 1996; 7: 2453-2460
12. Heimburger O, Lonnqvist F, Danielsson A et al. Serum immunoreactive leptin concentration and its relation to the body fat content in chronic renal failure. J Am Soc Nephrol 1997; 8: 1423-1430
13. Stenvinkel P. Leptin - a new hormone of definite interest for the nephrologist. Nephrol Dial Transplant 1998; 13: 1099-1101
14. Deppisch RM, Beck W, Goehl H, Ritz E. Complement components as uremic toxins and their potential role as mediators of microinflammation. Kidney Int 2001; 78 [Suppl]: S271-S277
15. Horl WH. Hemodialysis membranes: interleukins, biocompatibility, and middle molecules. J Am Soc Nephrol 2002; 13 [Suppl 1]: S62-S71
16. Clark WR, Gao D. Low-molecular weight proteins in end-stage renal disease: potential toxicity and dialytic removal mechanisms. J Am Soc Nephrol 2002; 13 [Suppl 1]: S41-S47
17. Ledebo I. On-line hemodiafiltration: technique and therapy. Adv Ren Replace Ther 1999; 6: 195-208
18. Lim PS, Lee HP, Kho B et al. Evaluation of pre- and postdilutional on-line hemodiafiltration adequacy by partial dialysate quantification and on-line urea monitor. Blood Purif 1999; 17: 199-205
19. Pedrini LA, de Cristofaro V, Pagliari B, Ruggiero P. Dialysate/infusate composition and infusion mode in on-line hemodialfiltration. Contrib Nephrol 2002; 137: 344-349
20. Ficheux A, Argiles A, Mion H, Mion CM. Influence of convection on small molecule clearances in online hemodiafiltration. Kidney Int 2000; 57: 1755-1763
21. Locatelli F, di Filippo S, Manzoni C. Removal of small and middle molecules by convective techniques. Nephrol Dial Transplant 2000; 15 [Suppl 2]: 37-44
22. Zehnder C, Gutzwiller JP, Renggli K. Hemodiafiltration - a new treatment option for hyperphosphatemia in hemodialysis patients. Clin Nephrol 1999; 52: 152-159
23. David S, Bostrom M, Cambi V. Predilution hemofiltration. Clinical experience and removal of small molecular weight solutes. Int J Artif Organs 1995; 18: 743-750
24. Vitale C, Marangella M, Ramello A. Dialysate/infusate calcium and magnesium. Contrib Nephrol 2002; 137: 350-356
25. Malberti F, Corradi B, Tetta C, Imbasciati E. Calcium balance and serum ionized calcium fluctuations in on-line haemodiafiltration in relation to ultrafiltration rate and dialysate calcium concentration. Nephrol Dial Transplant 1994; 9: 1759-1764
26. Argiles A, Mion CM. Calcium balance and intact PTH variations during haemodiafiltration. Nephrol Dial Transplant 1995; 10: 2083-2089
27. Ward RA, Schmidt B, Hullin J, Hillebrand G, Samtleben W. A comparison of on-line hemodiafiltration and high-flux hemodialysis: a prospective clinical study. J Am Soc Nephrol 2000; 11: 2344-2350
28. Lornoy W, Becaus I, Billiouw JM, Sierens L, van Malderen P, D'Haenens P. Online haemodiafiltration. Remarkable removal of beta2-microglobulin. Long-term clinical observations. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 49-54
29. Lin CL, Yang CW, Chiang CC, Chang CT, Huang CC. Long-term on-line hemodiafiltration reduces predialysis beta-2-microglobulin levels in chronic hemodialysis patients. Blood Purif 2001; 19: 301-307
30. Wiesholzer M, Harm F, Hauser AC, Pribasnig A, Balcke P. Inappropriately high plasma leptin levels in obese haemodialysis patients can be reduced by high flux haemodialysis and haemodiafiltration. Clin Sci (Lond) 1998; 94: 431-435
31. Nensel U, Rockel A, Hillenbrand T, Bartel J. Dialyzer permeability for low-molecular-weight proteins. Comparison between polysulfone, polyamide and cuprammonium-rayon dialyzers. Blood Purif 1994; 12: 128-134
32. Kramer BK, Pickert A, Hohmann C et al. In vivo clearance and elimination of nine marker substances during hemofiltration with different membranes. Int J Artif Organs 1992; 15: 408-412
33. 131I-beta2 microglobulin in hemodialysis patients: assessment using total body counting. Artif Organs 1998; 22: 574-580
34. Morena M, Cristol JP, Bosc JY et al. Convective and diffusive losses of vitamin C during haemodiafiltration session: a contributive factor to oxidative stress in haemodialysis patients. Nephrol Dial Transplant 2002; 17: 422-427
35. Altieri P, Sorba G, Bolasco P et al. Pre-dilution haemofiltration - the Sardinian multicenter studies: present and future. Nephrol Dial Transpl 2000; 15 [Suppl 2]: 55-59
36. Altieri P, Sorba G, Bolasco P et al. Pre-dilution haemofiltration - the second Sardinian multicenter study: comparisons between haemofiltration and haemodialysis during identical Kt/V and session times in a long term cross-over study. Nephrol Dial Transpl 2001; 16: 1207-1213
37. Wizeman V, Lotz C, Techert F. On-line haemodiafiltration versus low-flux haemodialysis. A prospective randomized study. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 43-48
38. Passlick-Deetjen J, Pohlmeier R. On-line haemodiafiltration: gold standard or top therapy. Contrib Nephrol 2002; 137: 201-211
39. Canaud B, Bosc JY, Leray H et al. Microbiological purity of dialysate for on-line substitution fluid preparation. Nephrol Dial Transplant 2000; 15 [Suppl 2]: 21-30
40. Ledebo I. On-line preparation of solutions for dialysis: practical aspects versus safety and regulations. J Am Soc Nephrol 2002; 13 [Suppl 1]: S78-S83
41. Pirovano D. Regulatory issues for on-line haemodiafiltration. Nephrol Dial Transplant 1998; 13 [Suppl 5]: 21-23
42. Bambauer R, Schauer M, Jung WK, Daum V, Vienken J. Contamination of dialysis water and dialysate. A survey of 30 centers. ASAIO J 1994; 40: 1012-1016
43. Penders C, Kooman JP, Stobberingh EE, van der Sande FM, Frederik PM, Leunissen KM. Does ultrapure dialysate prevent the development of biofilm in dialysis therapy? Nephrol Dial Transplant 2001; 16: 1522-1524
44. Canaud B, Wizemann V, Pizzarelli F et al. Cellular interleukin-1 receptor antagonist production in patients receiving on-line haemodiafiltration therapy. Nephrol Dial Transplant 2001; 16: 2181-2187
45. Vaslaki L, Karatson A, Voros P et al. Can sterile and pyrogen-free on-line substitution fluid be routinely delivered? A multicentric study on the microbiological safety of on-line haemodiafiltration. Nephrol Dial Transplant 2000; 15 [Suppl 1]: 74-78
46. Lonnemann G. On-line fluid preparation. Contrib Nephrol 2002; 137: 332-337
47. Ledebo I, Nystrand R. Defining the microbiological quality of dialysis fluid. Artif Organs 1999; 23: 37-43
48. Baldamus CA, Ernst W, Frei U, Koch KM. Sympathetic and hemodynamic response to volume removal during different forms of renal replacement therapy. Nephron 1982; 31: 324-332
49. Santoro A, Mancini E, Zucchelli P. The impact of haemofiltration on the systemic cardiovascular response. Nephrol Dial Transplant 2000; 15 [Suppl 2]: 49-54
50. van der Sande FM, Kooman JP, Leunissen KM. Intradialytic hypotension-new concepts on an old problem. Nephrol Dial Transplant 2000; 15: 1746-1748
51. van Kuijk WH, Hillion D, Savoiu C et al. Critical role of the extracorporeal blood temperature in the hemodynamic response during hemofiltration. J Am Soc Nephrol 1997; 8: 949-955
52. van der Sande FM, Kooman JP, Konings CJ, Leunissen KM. Thermal effects and blood pressure response during postdilution hemodiafiltration and hemodialysis: the effect of amount of replacement fluid and dialysate temperature. J Am Soc Nephrol 2001; 12: 1916-1920
53. Henderson LW. Hemodynamic instability during different forms of dialysis therapy: do we really know why? Blood Purif 1996; 14: 395-404
54. Ledebo I. On-line hemofiltration. Old concept - new approach. Contrib Nephrol 2002; 137: 221-226
55. Kooman JP, van der Sande FM, Leunissen KML. Predilution haemofiltration. Nephrol Dial Transplant 2002; 17: 171-172
56. Locatelli F, Marcelli D, Conte F et al. Comparison of mortality in ESRD patients on convective and diffusive extracorporeal treatments. Kidney Int 1999; 55: 286-293
57. Nakai S, Iseki K, Tabei K et al. Outcomes of hemodiafiltration based on Japanese dialysis patient registry. Am J Kidney Dis 2001; 38 [Suppl 1]: S212-S216
58. Maduell F, del Pozo C, Garcia H et al. Change from conventional haemodiafiltration to on-line haemodiafiltration. Nephrol Dial Transplant 1999; 14: 1202-1207
59. Schaefer K, Asmus G, Quellhorst E et al. Optimum dialysis treatment for patients over 60 years with primary renal disease. Survival data and clinical results from 242 patients treated either by haemodialysis or haemofiltration. Proc EDTA-ERA 1984; 21: 510-517
60. Quellhorst E, Scheunemann E, Mietzsch G. Long-term hemofiltration in 'poor risk' patients. Trans Am Soc Artif Intern Organs 1987; XXXIII: 758-764